Standout Papers
- Targeting PI3K in cancer: mechanisms and advances in clinical trials (2019)
- Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials (2019)
- Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency (2022)
- Preparation and application of pH-responsive drug delivery systems (2022)
- Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance (2023)
- Targeted therapy for head and neck cancer: signaling pathways and clinical studies (2023)
- Metabolic reprogramming in cancer: Mechanisms and therapeutics (2023)
Immediate Impact
3 by Nobel laureates 13 from Science/Nature 61 standout
Citing Papers
Lactate controls cancer stemness and plasticity through epigenetic regulation
2025 Standout
A vision–language foundation model for precision oncology
2025 StandoutNature
Works of Xuelei Ma being referenced
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis
2022
The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xuelei Ma | 3202 | 1359 | 1823 | 3515 | 306 | 9.8k | |
| So Yeon Park | 3427 | 1467 | 1591 | 3295 | 458 | 11.3k | |
| Eugene P. Frenkel | 2526 | 661 | 1402 | 3087 | 201 | 9.3k | |
| David R. Spriggs | 4808 | 651 | 1838 | 4177 | 229 | 12.8k | |
| Noriaki Ohuchi | 3321 | 1163 | 1316 | 3064 | 378 | 9.4k | |
| Hiroaki Kajiyama | 2390 | 2205 | 926 | 3123 | 413 | 9.8k | |
| Rainer Kimmig | 3537 | 841 | 1173 | 2202 | 395 | 10.0k | |
| Gang Huang | 1773 | 1562 | 1303 | 4358 | 373 | 9.4k | |
| King‐Jen Chang | 3621 | 777 | 1678 | 4059 | 326 | 10.9k | |
| Theodore L. DeWeese | 2701 | 1446 | 4035 | 3042 | 224 | 9.8k | |
| Ömer Yılmaz | 2192 | 1734 | 792 | 4446 | 400 | 12.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...